Skip to main content
NVDA-2.20%AAPL+2.47%GOOGL+0.41%MSFT+0.45%AMZN+0.20%TSM-0.95%SPCX+2.27%AVGO-0.23%META-0.29%TSLA-0.55%SKHY-3.91%MU-4.61%BRK-B-0.13%LLY+0.29%JPM-0.55%WMT+0.13%AMD-2.90%V0.00%XOM+0.67%ASMLa-1.66%JNJ-0.14%INTC-4.65%MA-0.34%0700.HK-1.94%1398.HK+0.79%ORCL-3.13%ABBV+0.58%BAC-0.61%CSCO-0.87%CVX-0.12%COST+0.09%KO+0.93%LRCX-4.74%CAT-1.65%AP2d-1.55%0005.HK-0.78%AMAT-2.40%UNH-0.33%HSBA.L-1.30%DELL-3.52%PG-0.07%MS-0.55%GE-0.51%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX+0.25%HD-1.31%0939.HK+1.66%GS-0.71%NZDJPY-2.51%AUDJPY-1.77%CHFJPY-1.56%NZDCAD-1.40%EURNZD+1.34%GBPNZD+1.31%NZDUSD-1.28%USDJPY-1.27%EURJPY-1.21%GBPJPY-1.21%CADJPY-1.13%NZDCHF-0.98%USDZAR+0.90%USDNOK+0.85%USDSEK+0.84%EURZAR+0.78%AUDNZD+0.77%EURNOK+0.73%GBPZAR+0.72%EURSEK+0.72%AUDCAD-0.67%CHFNOK+0.60%AUDDKK-0.59%CHFSEK+0.59%EURAUD+0.56%GBPAUD+0.54%USDTHB+0.53%AUDUSD-0.51%AUDSGD-0.49%USDMXN+0.43%CADCHF+0.42%GBPTRY+0.41%NOKJPY-0.38%USDPLN+0.37%EURCHF+0.34%GBPCHF+0.34%NZDSGD-0.33%GBPHKD+0.32%USDCHF+0.31%GBPMXN-0.28%SGDJPY+0.25%EURPLN+0.24%USDSGD+0.22%AUDCHF-0.21%USDILS+0.16%NZDMXN-0.14%AUDNOK+0.14%EURHKD-0.13%USDCAD-0.12%USDDKK+0.12%PLNJPY+0.11%USDTRY+0.11%GBPCAD-0.10%EURSGD+0.10%EURCAD-0.09%USDCNH+0.08%EURCZK-0.08%GBPUSD+0.05%EURUSD+0.04%USDCOP-0.04%GBPSGD+0.03%CHFSGD-0.03%EURCNH-0.02%EURGBP+0.02%USDHKD+0.01%EURDKK0.00%XPTUSD-5.48%UKOIL+4.70%HG1-4.42%GAGUSD-4.41%XAGUSD-4.41%USOIL+4.32%GAUUSD-0.86%XAUUSD-0.86%COTTON+0.84%S1+0.62%COFFEE-0.45%XNGUSD+0.40%BTCUSD-1.43%ETHUSD-0.77%USDTUSD-0.03%XRPUSD-2.97%SOLUSD-1.84%TRXUSDT-0.03%ZECUSDT-8.96%DOGEUSD-3.07%XMRUSDT-1.30%LINKUSD-1.61%XLMUSD-2.13%BCHUSDT-9.79%LTCUSD-1.81%UNIUSD-2.69%TONUSD+24.88%HBARUSDT-2.50%SUIUSD-3.99%TAOUSDT-5.12%AAVEUSD-2.93%DOTUSDT-3.07%ICPUSDT-2.16%ONDOUSDT-3.62%WLDUSDT-3.39%ATOMUSDT-3.78%ARBUSDT-1.07%JUPUSDT-4.67%INJUSDT-4.10%STXUSDT-4.53%FETUSDT-4.10%TIAUSDT-2.18%PYTHUSDT-1.58%SEIUSDT-6.02%IMXUSDT-3.85%GRTUSDT-3.37%WIFUSDT-5.38%OPUSDT-3.00%POLUSDT-4.92%IOTAUSDT-4.20%AXSUSDT-2.47%FARTCOINUSDT-4.23%EOSUSDT-3.15%DYDXUSDT-2.98%ORDIUSDT-1.84%GALAUSDT-4.21%NOTUSDT-2.97%RONINUSDT-2.64%NVDA-2.20%AAPL+2.47%GOOGL+0.41%MSFT+0.45%AMZN+0.20%TSM-0.95%SPCX+2.27%AVGO-0.23%META-0.29%TSLA-0.55%SKHY-3.91%MU-4.61%BRK-B-0.13%LLY+0.29%JPM-0.55%WMT+0.13%AMD-2.90%V0.00%XOM+0.67%ASMLa-1.66%JNJ-0.14%INTC-4.65%MA-0.34%0700.HK-1.94%1398.HK+0.79%ORCL-3.13%ABBV+0.58%BAC-0.61%CSCO-0.87%CVX-0.12%COST+0.09%KO+0.93%LRCX-4.74%CAT-1.65%AP2d-1.55%0005.HK-0.78%AMAT-2.40%UNH-0.33%HSBA.L-1.30%DELL-3.52%PG-0.07%MS-0.55%GE-0.51%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX+0.25%HD-1.31%0939.HK+1.66%GS-0.71%NZDJPY-2.51%AUDJPY-1.77%CHFJPY-1.56%NZDCAD-1.40%EURNZD+1.34%GBPNZD+1.31%NZDUSD-1.28%USDJPY-1.27%EURJPY-1.21%GBPJPY-1.21%CADJPY-1.13%NZDCHF-0.98%USDZAR+0.90%USDNOK+0.85%USDSEK+0.84%EURZAR+0.78%AUDNZD+0.77%EURNOK+0.73%GBPZAR+0.72%EURSEK+0.72%AUDCAD-0.67%CHFNOK+0.60%AUDDKK-0.59%CHFSEK+0.59%EURAUD+0.56%GBPAUD+0.54%USDTHB+0.53%AUDUSD-0.51%AUDSGD-0.49%USDMXN+0.43%CADCHF+0.42%GBPTRY+0.41%NOKJPY-0.38%USDPLN+0.37%EURCHF+0.34%GBPCHF+0.34%NZDSGD-0.33%GBPHKD+0.32%USDCHF+0.31%GBPMXN-0.28%SGDJPY+0.25%EURPLN+0.24%USDSGD+0.22%AUDCHF-0.21%USDILS+0.16%NZDMXN-0.14%AUDNOK+0.14%EURHKD-0.13%USDCAD-0.12%USDDKK+0.12%PLNJPY+0.11%USDTRY+0.11%GBPCAD-0.10%EURSGD+0.10%EURCAD-0.09%USDCNH+0.08%EURCZK-0.08%GBPUSD+0.05%EURUSD+0.04%USDCOP-0.04%GBPSGD+0.03%CHFSGD-0.03%EURCNH-0.02%EURGBP+0.02%USDHKD+0.01%EURDKK0.00%XPTUSD-5.48%UKOIL+4.70%HG1-4.42%GAGUSD-4.41%XAGUSD-4.41%USOIL+4.32%GAUUSD-0.86%XAUUSD-0.86%COTTON+0.84%S1+0.62%COFFEE-0.45%XNGUSD+0.40%BTCUSD-1.43%ETHUSD-0.77%USDTUSD-0.03%XRPUSD-2.97%SOLUSD-1.84%TRXUSDT-0.03%ZECUSDT-8.96%DOGEUSD-3.07%XMRUSDT-1.30%LINKUSD-1.61%XLMUSD-2.13%BCHUSDT-9.79%LTCUSD-1.81%UNIUSD-2.69%TONUSD+24.88%HBARUSDT-2.50%SUIUSD-3.99%TAOUSDT-5.12%AAVEUSD-2.93%DOTUSDT-3.07%ICPUSDT-2.16%ONDOUSDT-3.62%WLDUSDT-3.39%ATOMUSDT-3.78%ARBUSDT-1.07%JUPUSDT-4.67%INJUSDT-4.10%STXUSDT-4.53%FETUSDT-4.10%TIAUSDT-2.18%PYTHUSDT-1.58%SEIUSDT-6.02%IMXUSDT-3.85%GRTUSDT-3.37%WIFUSDT-5.38%OPUSDT-3.00%POLUSDT-4.92%IOTAUSDT-4.20%AXSUSDT-2.47%FARTCOINUSDT-4.23%EOSUSDT-3.15%DYDXUSDT-2.98%ORDIUSDT-1.84%GALAUSDT-4.21%NOTUSDT-2.97%RONINUSDT-2.64%
HT

Heron Therapeutics, Inc. (HRTX)

NASDAQ • Healthcare

$0.33
-$0.01 (-4.9%)
Market open

Last close at September 9, 2026 at 20:00 UTC

Open$0.34
Previous Close$0.33
Day Range$0.33 - $0.35
Avg. Volume (3M)2.3M
Market Cap$61.2M
52 Week Range
$0.3$1.58
Next EarningsIn 54 daysNov 3, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$37.6M100%
Gross Profitminus cost of goods$26M69%

In plain terms: out of every $100 in revenue, Heron Therapeutics, Inc. currently loses $15.

Fundamentals & Financials

Revenue (TTM)
$151.1M
Net Income (TTM)
-$34M
EPS (TTM)
-$0.19
ROA (TTM)
-13.5%
Current Ratio
2.49

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+33.3%Q1 2026-$0.02
-33.3%Q2 2026-$0.04
-500.0%Q3 2026-$0.03
Next

Nov 3

in 54 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

View full earnings history

About Heron Therapeutics, Inc.

Heron Therapeutics, Inc. develops and markets biotechnology medicines for oncology supportive care and acute pain, and trades on the NASDAQ under HRTX. The company generated $154.9 million in FY2025 revenue. Heron centers its commercial business on SUSTOL and CINVANTI, two therapies used to prevent chemotherapy-induced nausea and vomiting.

Name
Heron Therapeutics, Inc.
CEO
Craig Alexander Collard
Website
www.herontx.com
Industry
Healthcare
Year Founded
1983
Employees
128

Today's Snapshot

AI-generated

So far today, HRTX is trading 2.5% lower at 0.32, while its sector was flat.

Trading Volume

Below 10d avg (1.6M)

603K

vs S&P 500 Today

Underperforming Market

-1.99%

Updated: September 10, 2026 at 16:58 UTC

Technical Indicators

0 Buy3 Neutral5 Sell
HRTX carries a strong sell profile as the price is well below most moving averages, including the 200-day, reflecting sustained longer-term weakness. Momentum readings are muted to negative and the MACD sits marginally below zero, while the CCI does not show strength; the RSI is in the lower-mid range. ADX above 25 indicates a meaningful directional move to the downside, ATR near 8.7% points to elevated volatility, and OBV shows material distribution. Technical takeaway: strong sell bias driven by a defined downtrend, elevated volatility and persistent selling pressure.
All signals
  • EMA (5 indicators)$0.33 - $0.80
    Sell
  • RSI (14)40.37
    Neutral
  • Stochastic %K (14, 3, 3)66.41
    Neutral
  • MACD Level (12, 26)-0.02
    Neutral

Peers & Related Assets

SLSSELLAS Life Sciences Group, Inc.
$13.95-0.1%
OABIOmniAb, Inc.
$4.01-5.4%
CHRSCoherus Oncology, Inc.
$1.32-3.6%
GNFTGenfit S.A.
EPRXEupraxia Pharmaceuticals Inc.
IVVDInvivyd, Inc.
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.